Serum proteomics reveals systemic dysregulation of innate immunity in type 1 diabetes
Qibin Zhang(Dalian University of Technology), Thomas Metz(Pacific Northwest National Laboratory), Athena Schepmoes(Pacific Northwest National Laboratory), Therese RW Clauss(Pacific Northwest National Laboratory), Marian Rewers(University of Colorado Denver), Mark A. Atkinson(University of Florida), Richard Smith(Salisbury NHS Foundation Trust), Patricia W. Mueller(Centers for Disease Control and Prevention), Thomas Fillmore(Pacific Northwest National Laboratory)
Cited by 105
Related Papers
Type 1 diabetes
|The Lancet|2013|2.7k
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
|The Lancet|2001|1.5k
Staging Presymptomatic Type 1 Diabetes: A Scientific Statement of JDRF, the Endocrine Society, and the American Diabetes Association
|Diabetes Care|2015|1.2k
The Pathogenesis of Insulin-Dependent Diabetes Mellitus
|New England Journal of Medicine|1994|1.1k